AROA is pleased to release its audited full year results for the period ended 31 March 2023. Highlights are listed…
The inaugural Biotech NZ Life Sciences Summit was held in Wellington on March 22 and 23, with the theme, Biotech…
Read MoreHighlights AROA has been awarded a group purchasing agreement for its Myriad™ and Symphony™ products, with Premier, Inc. – a…
Read MoreFirst of its kind study shows promising results for combined use of negative pressure wound therapy and AROA’s EndoformTM High…
Read MoreAroa Biosurgery Limited (ASX: ARX, ‘AROA’ or the ‘Company’) is pleased to provide an update on its activities for the…
Read MoreToday Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. With fewer COVID-19 related disruptions,…
Read MoreAroa Biosurgery, (AROA) is delighted to announce the appointment of award-winning medical researcher and inventor, Dr. Catherine Mohr as a…
Read MoreSoft tissue regeneration company Aroa Biosurgery Limited (ASX:ARX, ‘AROA’ or the ‘Company’)advises that following recent incidences of COVID-19 amongst staff…
Read MoreToday Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. With fewer COVID-19 related disruptions,…
Read MoreHighlights A retrospective analysis of real-world data published in the ‘International Wound Journal’ compared the wound closure times for diabetic…
Read More